Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
|Active Ingredient:||Abiraterone acetate 125mg|
|New Zealand Sponsor:||CARSL Consulting|
|Manufacturer:||Mayne Pharma Inc, North Carolina, United States of America|
Dated this 8th day of October 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).